ZENAPAX

Zenapax Adverse Events Reported to the FDA Over Time

How are Zenapax adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zenapax, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zenapax is flagged as the suspect drug causing the adverse event.

Most Common Zenapax Adverse Events Reported to the FDA

What are the most common Zenapax adverse events reported to the FDA?

Pyrexia	38 (1.89%)
Cytomegalovirus Infection	37 (1.84%)
Transplant Rejection	34 (1.69%)
Blood Creatinine Increased	32 (1.59%)
Infection	29 (1.44%)
Kidney Transplant Rejection	29 (1.44%)
Pyelonephritis	26 (1.29%)
Complications Of Transplanted Kidne...	25 (1.24%)
Diarrhoea	23 (1.14%)
Sepsis	21 (1.04%)
Drug Ineffective	19 (.94%)
	Show More
Haemoglobin Decreased	19 (.94%)
Anaemia Haemolytic Autoimmune	18 (.89%)
Blood Glucose Increased	16 (.79%)
Abdominal Pain	15 (.74%)
Dehydration	15 (.74%)
Hypotension	15 (.74%)
Acute Respiratory Distress Syndrome	14 (.69%)
Anaemia	14 (.69%)
Urinary Tract Infection	14 (.69%)
Aplasia Pure Red Cell	13 (.65%)
Graft Dysfunction	13 (.65%)
Haematocrit Decreased	13 (.65%)
Hypertension	13 (.65%)
Atelectasis	12 (.6%)
Enterococcal Infection	12 (.6%)
Vomiting	12 (.6%)
Pleural Effusion	11 (.55%)
Renal Failure	11 (.55%)
Haemodialysis	10 (.5%)
Hepatic Enzyme Increased	10 (.5%)
Nausea	10 (.5%)
Acute Pulmonary Oedema	9 (.45%)
Bone Marrow Failure	9 (.45%)
Condition Aggravated	9 (.45%)
Dyspnoea	9 (.45%)
Graft Versus Host Disease	9 (.45%)
Renal Failure Acute	9 (.45%)
Blood Urea Increased	8 (.4%)
Candidiasis	8 (.4%)
Fatigue	8 (.4%)
Febrile Neutropenia	8 (.4%)
Hypoxia	8 (.4%)
Immunosuppression	8 (.4%)
Liver Transplant Rejection	8 (.4%)
Lung Disorder	8 (.4%)
Multi-organ Failure	8 (.4%)
Oedema Peripheral	8 (.4%)
Septic Shock	8 (.4%)
Tachycardia	8 (.4%)
Toxoplasmosis	8 (.4%)
White Blood Cell Count Decreased	8 (.4%)
Alanine Aminotransferase Increased	7 (.35%)
Aspartate Aminotransferase Increase...	7 (.35%)
Bacterial Infection	7 (.35%)
Bile Duct Stenosis	7 (.35%)
Deep Vein Thrombosis	7 (.35%)
Drug Toxicity	7 (.35%)
Gastrointestinal Haemorrhage	7 (.35%)
Hallucination	7 (.35%)
Hepatotoxicity	7 (.35%)
Renal Impairment	7 (.35%)
Renal Tubular Necrosis	7 (.35%)
Staphylococcal Infection	7 (.35%)
Aspergillosis	6 (.3%)
Bk Virus Infection	6 (.3%)
Blood Culture Positive	6 (.3%)
Blood Sodium Decreased	6 (.3%)
Bronchitis	6 (.3%)
Cellulitis	6 (.3%)
Chest Pain	6 (.3%)
Complications Of Transplanted Liver	6 (.3%)
Cytomegalovirus Antigen Positive	6 (.3%)
Escherichia Infection	6 (.3%)
Escherichia Urinary Tract Infection	6 (.3%)
Headache	6 (.3%)
Hepatic Failure	6 (.3%)
Hepatic Steatosis	6 (.3%)
Human Herpesvirus 8 Infection	6 (.3%)
Morganella Infection	6 (.3%)
Pancytopenia	6 (.3%)
Pelvic Abscess	6 (.3%)
Transaminases Increased	6 (.3%)
Ventricular Tachycardia	6 (.3%)
Asphyxia	5 (.25%)
Brain Oedema	5 (.25%)
Cardiac Arrest	5 (.25%)
Drug Ineffective For Unapproved Ind...	5 (.25%)
Dysuria	5 (.25%)
Fluid Overload	5 (.25%)
Fungal Infection	5 (.25%)
Gastroenteritis	5 (.25%)
Haematoma Infection	5 (.25%)
Hepatic Neoplasm Malignant	5 (.25%)
Hyperkalaemia	5 (.25%)
Hypokalaemia	5 (.25%)
Hypovolaemia	5 (.25%)
Ileus	5 (.25%)
Immunosuppressant Drug Level Increa...	5 (.25%)
Interstitial Lung Disease	5 (.25%)
Klebsiella Infection	5 (.25%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Zenapax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zenapax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zenapax

What are the most common Zenapax adverse events reported to the FDA?

Infections - Pathogen Unspecified	196 (9.73%)
Bacterial Infectious	105 (5.21%)
Immune	83 (4.12%)
Procedural And Device Related Injur...	77 (3.82%)
Viral Infectious	75 (3.72%)
Hematology Investigations	67 (3.33%)
Respiratory	54 (2.68%)
Lower Respiratory Tract Disorders	53 (2.63%)
Renal And Urinary Tract Investigati...	53 (2.63%)
Renal Disorders	48 (2.38%)
Gastrointestinal Signs	46 (2.28%)
	Show More
Anemias Nonhemolytic And Marrow Dep...	42 (2.08%)
Electrolyte And Fluid Balance Condi...	39 (1.94%)
Body Temperature Conditions	38 (1.89%)
Hepatic And Hepatobiliary	32 (1.59%)
Therapeutic And Nontherapeutic Effe...	31 (1.54%)
Cardiac Arrhythmias	30 (1.49%)
Hepatobiliary	30 (1.49%)
Gastrointestinal Motility And Defec...	29 (1.44%)
Fungal Infectious	27 (1.34%)
Epidermal And Dermal Conditions	24 (1.19%)
Microbiology And Serology	24 (1.19%)
Decreased And Nonspecific Blood Pre...	22 (1.09%)
Hemolyses And Related Conditions	22 (1.09%)
Water, Electrolyte And Mineral	22 (1.09%)
Cardiac And Vascular Investigations	20 (.99%)
Metabolic, Nutritional And Blood Ga...	18 (.89%)
White Blood Cell	18 (.89%)
Pleural	17 (.84%)
Hematological And Lymphoid Tissue T...	16 (.79%)
Neurological	16 (.79%)
Nephropathies	15 (.74%)
Injuries	14 (.69%)
Coronary Artery	13 (.65%)
Physical Examination Topics	13 (.65%)
Vascular Hypertensive	13 (.65%)
Bile Duct	12 (.6%)
Gastrointestinal Hemorrhages	12 (.6%)
Toxicology And Therapeutic Drug Mon...	11 (.55%)
Gastrointestinal Stenosis And Obstr...	10 (.5%)
Vascular	10 (.5%)
Glucose Metabolism Disorders	9 (.45%)
Protozoal Infectious	9 (.45%)
Vision	9 (.45%)
Acid-base	8 (.4%)
Administration Site Reactions	8 (.4%)
Embolism And Thrombosis	8 (.4%)
Immunodeficiency Syndromes	8 (.4%)
Musculoskeletal And Connective Tiss...	8 (.4%)
Urinary Tract Signs	8 (.4%)
Chemical Injury And Poisoning	7 (.35%)
Disturbances In Thinking	7 (.35%)
Enzyme	7 (.35%)
Gastrointestinal Ulceration And Per...	7 (.35%)
Peritoneal And Retroperitoneal Cond...	7 (.35%)
Skin Appendage Conditions	7 (.35%)
Therapeutic Procedures And Supporti...	7 (.35%)
Anxiety Disorders	6 (.3%)
Appetite And General Nutritional	6 (.3%)
Arteriosclerosis, Stenosis, Vascula...	6 (.3%)
Cardiac Disorder Signs	6 (.3%)
Headaches	6 (.3%)
Metastases	6 (.3%)
Platelet	6 (.3%)
Respiratory And Mediastinal Neoplas...	6 (.3%)
Tissue	6 (.3%)
Cardiac Valve	5 (.25%)
Central Nervous System Infections A...	5 (.25%)
Dental And Gingival Conditions	5 (.25%)
Gastrointestinal Inflammatory Condi...	5 (.25%)
Hematopoietic Neoplasms	5 (.25%)
Hepatobiliary Neoplasms Malignant A...	5 (.25%)
Increased Intracranial Pressure And...	5 (.25%)
Miscellaneous And Site Unspecified ...	5 (.25%)
Muscle	5 (.25%)
Pulmonary Vascular	5 (.25%)
Vascular Hemorrhagic	5 (.25%)
Abdominal Hernias And Other Abdomin...	4 (.2%)
Bladder And Bladder Neck Disorders	4 (.2%)
Bone, Calcium, Magnesium And Phosph...	4 (.2%)
Bronchial Disorders	4 (.2%)
Coagulopathies And Bleeding Diathes...	4 (.2%)
Cornification And Dystrophic Skin	4 (.2%)
Deliria	4 (.2%)
Exocrine Pancreas Conditions	4 (.2%)
Gastrointestinal	4 (.2%)
Gastrointestinal Vascular Condition...	4 (.2%)
Lymphatic Vessel	4 (.2%)
Metabolic And Nutritional Disorders...	4 (.2%)
Myocardial	4 (.2%)
Pericardial	4 (.2%)
Seizures	4 (.2%)
Spleen, Lymphatic And Reticulendoth...	4 (.2%)
Upper Respiratory Tract Disorders	4 (.2%)
Allergic Conditions	3 (.15%)
Breast Neoplasms Malignant And Unsp...	3 (.15%)
Cranial Nerve Disorders	3 (.15%)
Encephalopathies	3 (.15%)
Fatal Outcomes	3 (.15%)
Gastrointestinal Conditions	3 (.15%)
Gastrointestinal Neoplasms Malignan...	3 (.15%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zenapax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zenapax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.